People with MS are often advised to take high doses of vitamin D, but there’s been very little research to assess what effect this might have.
Effect of vitamin D supplements on MS activity
Posts in the MS News category:
The Evidence for Oxygen awarded the 2019 Nobel prize
We wanted to draw attention to an interesting article published in the HBOTT Dec 2019 Newsletter.
Tysabri: reducing the risk of PML with extended interval dosing
Tysabri (natalizumab) is very effective for people with highly active relapsing remitting MS but it carries the risk of developing a rare but very serious brain infection called progressive multifocal leukoencephalopathy (PML).
Sativex approved by NICE
Sativex, a cannabis based drug for MS related spasticity, has been approved by NICE as a cost effective treatment for the NHS in England.
Siponimod recommended for secondary progressive MS by EMA
The European Medicines Agency has recommended that a licence should be granted for Siponimod for the treatment of active secondary progressive MS.
Rex Robotic Exoskeleton Trial
East Kent leads the way in robotic trials to improve patients’ mobility.